ABC-transporters: Implications on drug resistance from microorganisms to human cancers

International Journal of Antimicrobial Agents

Volumn 22, Issue 3, 2003, Pages 188-199

  Lage, Hermann ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Efflux pumps; Membrane protein; Multidrug resistance; Permease; Xenobiotics transport

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; ABC TRANSPORTER; AMINOGLYCOSIDE; ANTHRACYCLINE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; ARTEMISININ; CHLORAMPHENICOL; CHLOROQUINE; DAUNORUBICIN; DOXORUBICIN; ERYTHROMYCIN; FUNGICIDE; HALOFANTRINE; LINCOSAMIDE; MACROLIDE; MEFLOQUINE; MONENSIN; NOVOBIOCIN; PHENANTHROLINE; QUININE; QUINOLONE DERIVATIVE; STREPTOGRAMIN DERIVATIVE; TETRACYCLINE DERIVATIVE; TETRONASIN; TRIAZIQUONE; VINCA ALKALOID;

ANTIBIOTIC THERAPY; ARCHAEBACTERIUM; CANCER; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CANDIDA ALBICANS; CELL FUNCTION; DRUG BINDING; DRUG MECHANISM; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; ENTAMOEBA HISTOLYTICA; EUBACTERIUM; EUKARYOTE; HALOFERAX VOLCANII; HUMAN; INFECTION; LACTOBACILLUS BREVIS; LACTOCOCCUS LACTIS; LEISHMANIA; LEISHMANIA TARENTOLAE; MULTIDRUG RESISTANCE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROKARYOTE; PROTEIN FAMILY; REVIEW; SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOMYCES; STRUCTURE ACTIVITY RELATION; TUMOR CELL; XENOBIOTIC METABOLISM;

EID: 0041833334     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00203-6     Document Type: Article

References (139)

1. Jacoby G.A. Extrachromosomal resistance in gram-negative organisms: the evolution of beta-lactamase. Trends Microbiol. 2:1994;357-360.
2. Ling V. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother. Pharmacol. 40:(Suppl):1997;S3-S8.
3. Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer. 2:2002;48-58.
4. Van Bambeke F., Balzi E., Tulkens P.M. Antibiotic efflux pumps. Biochem. Pharmacol. 60:2000;457-470.
5. Hannun Y.A. Apoptosis and the dilemma of cancer chemotherapy. Blood. 89:1997;1845-1853.
6. Lowe S.W., Ruley H.E., Jacks T., Housman D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967.
7. McHugh P.J., Spanswick V.J., Hartley J.A. Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol. 2:2001;483-490.
8. Lage H., Dietel M. Involvement of the DNA mismatch repair system in antineoplastic drug resistance. J. Cancer Res. Clin. Oncol. 125:1999;156-165.
9. Tew K.D., Ronai Z. GST function in drug and stress response. Drug Resist. Updat. 2:1999;143-147.
10. Dietel M., Arps H., Lage H., Niendorf A. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257. Cancer Res. 50:1990;6100-6106.
11. Shen D., Pastan I., Gottesman M.M. Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins. Cancer Res. 58:1998;268-275.
12. Blackmore C.G., McNaughton P.A., van Veen H.W. Multidrug transporters in prokaryotic and eukaryotic cells: physiological functions and transport mechanisms. Mol. Membr. Biol. 18:2001;97-103.
13. Higgins C.F. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8:1992;67-113.
14. Paulsen I.T., Brown M.H., Skurray R.A. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60:1996;575-608.
15. Putman M., van Veen H.W., Konings W.N. Molecular properties of bacterial multidrug transporters. Microbiol. Mol. Biol. Rev. 64:2000;672-693.
16. Walker J.E., Saraste M., Runswick M.J., Gay N.J. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO. J. 1:1982;945-951.
17. Hyde S.C., Emsley P., Hartshorn M.J., et al. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature. 346:1990;362-365.
18. Barrasa M.I., Tercero J.A., Lacalle R.A., Jimenez A. The ard1 gene from Streptomyces capreolus encodes a polypeptide of the ABC-transporters superfamily which confers resistance to the aminonucleoside antibiotic A201A. Eur. J. Biochem. 228:1995;562-569.
19. Linton K.J., Cooper H.N., Hunter I.S., Leadlay P.F. An ABC-transporter from Streptomyces longisporoflavus confers resistance to the polyether-ionophore antibiotic tetronasin. Mol. Microbiol. 11:1994;777-785.
20. Ross J.I., Eady E.A., Cove J.H., Cunliffe W.J., Baumberg S., Wootton J.C. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol. Microbiol. 4:1990;1207-1214.
21. Guilfoile P.G., Hutchinson C.R. A bacterial analog of the mdr gene of mammalian tumor cells is present in Streptomyces peucetius, the producer of daunorubicin and doxorubicin. Proc. Natl. Acad. Sci. USA. 88:1991;8553-8557.
22. Bolhuis H., Molenaar D., Poelarends G., et al. Proton motive force-driven and ATP-dependent drug extrusion systems in multidrug-resistant Lactococcus lactis. J. Bacteriol. 176:1994;6957-6964.
23. van Veen H.W., Venema K., Bolhuis H., et al. Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. Proc. Natl. Acad. Sci. USA. 93:1996;10668-10672.
24. van Veen H.W., Margolles A., Muller M., Higgins C.F., Konings W.N. The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism. EMBO. J. 19:2000;2503-2514.
25. van Veen H.W., Callaghan R., Soceneantu L., Sardini A., Konings W.N., Higgins C.F. A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein gene. Nature. 391:1998;291-295.
26. Poelarends G.J., Mazurkiewicz P., Konings W. Multidrug transporters and antibiotic resistance in Lactococcus lactis. Biochim. Biophys. Acta. 1555:2002;1-7.
27. Poelarends G.J., Mazurkiewicz P., Putman M., Cool R.H., Veen H.W., Konings W.N. An ABC-type multidrug transporter of Lactococcus lactis possesses an exceptionally broad substrate specificity. Drug Resist. Updat. 3:2000;330-334.
28. van Helvoort A., Smith A.J., Sprong H., et al. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell. 87:1996;507-517.
29. Pohl A., Lage H., Müller P., Pomorski T., Herrmann A. Transport of phosphatidylserine via MDR1 (multidrug resistance1) P-glycoprotein in a human gastric carcinoma cell line. Biochem. J. 365:2002;259-268.
30. Margolles A., Putman M., van Veen H.W., Konings W.N. The purified and functionally reconstituted multidrug transporter LmrA of Lactococcus lactis mediates the transbilayer movement of specific fluorescent phospholipids. Biochemistry. 38:1999;16298-16306.
31. Sakamoto K., Margolles A., van Veen H.W., Konings W.N. Hop resistance in the beer spoilage bacterium Lactobacillus brevis is mediated by the ATP-binding cassette multidrug transporter HorA. J. Bacteriol. 183:2001;5371-5375.
32. Simpson W.J., Smith A.R. Factors affecting antibacterial activity of hop compounds and their derivatives. J. Appl. Bacteriol. 72:1992;327-334.
33. Miyauchi S., Komatsubara M., Kamo N. In archaebacteria, there is a doxorubicin efflux pump similar to mammalian P-glycoprotein. Biochim. Biophys. Acta. 1110:1992;144-150.
34. Kaidoh K., Miyauchi S., Abe A., Tanabu S., Nara T., Kamo N. Rhodamine 123 efflux transporter in Haloferax volcanii is induced when cultured under 'metabolic stress' by amino acids: the efflux system resembles that in a doxorubicin-resistant mutant. Biochem. J. 314:1996;355-359.
35. Young J., Holland I.B. ABC transporters: bacterial exporters-revisited five years on. Biochim. Biophys. Acta. 1461:1999;177-200.
36. Zhou Z., White K.A., Polissi A., Georgopoulos C., Raetz C.R. Function of Escherichia coli MsbA, an essential ABC family transporter, in lipid A and phospholipid biosynthesis. J. Biol. Chem. 273:1998;12466-12475.
37. Blattner F.R., Plunkett G. III, Bloch C.A., et al. The complete genome sequence of Escherichia coli K-12. Science. 277:1997;1453-1474.
38. Linton K.J., Higgins C.F. The Escherichia coli ATP-binding cassette (ABC) proteins. Mol. Microbiol. 28:1998;5-13.
39. McGrath J.P., Varshavsky A. The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein. Nature. 340:1989;400-404.
40. Decottignies A., Goffeau A. Complete inventory of the yeast ABC proteins. Nat. Genet. 15:1997;137-145.
41. Bissinger P.H., Kuchler K. Molecular cloning and expression of the Saccharomyces cerevisiae STS1 gene product. A yeast ABC transporter conferring mycotoxin resistance. J. Biol. Chem. 269:1994;4180-4186.
42. Kolaczkowski M., van der Rest M., Cybularz-Kolaczkowska A., Soumillion J.P., Konings W.N., Goffeau A. Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p. J. Biol. Chem. 271:1996;31543-31548.
43. Kolaczkowski M., Kolaczowska A., Luczynski J., Witek S., Goffeau A. In vivo characterization of the drug resistance profile of the major ABC transporters and other components of the yeast pleiotropic drug resistance network. Microb. Drug Resist. 4:1998;143-158.
44. Piper P., Mahe Y., Thompson S., et al. The pdr12 ABC transporter is required for the development of weak organic acid resistance in yeast. EMBO. J. 17:1998;4257-4265.
45. Holyoak C.D., Bracey D., Piper P.W., Kuchler K., Coote P.J. The Saccharomyces cerevisiae weak-acid-inducible ABC transporter Pdr12 transports fluorescein and preservative anions from the cytosol by an energy-dependent mechanism. J. Bacteriol. 181:1999;4644-4652.
46. Servos J., Haase E., Brendel M. Gene SNQ2 of Saccharomyces cerevisiae, which confers resistance to 4-nitroquinoline-N-oxide and other chemicals, encodes a 169 kDa protein homologous to ATP-dependent permeases. Mol. Gen. Genet. 236:1993;214-218.
47. Katzmann D.J., Hallstrom T.C., Voet M., et al. Expression of an ATP-binding cassette transporter-encoding gene (YOR1) is required for oligomycin resistance in Saccharomyces cerevisiae. Mol. Cell. Biol. 15:1995;6875-6883.
48. Decottignies A., Grant A.M., Nichols J.W., de Wet H., McIntosh D.B., Goffeau A. ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J. Biol. Chem. 273:1998;12612-12622.
49. Rebbeor J.F., Connolly G.C., Dumont M.E., Ballatori N. ATP-dependent transport of reduced glutathione on YCF1, the yeast orthologue of mammalian multidrug resistance associated proteins. J. Biol. Chem. 273:1998;33449-33454.
50. Katzmann D.J., Epping E.A., Moye-Rowley W.S. Mutational disruption of plasma membrane trafficking of Saccharomyces cerevisiae Yor1p, a homologue of mammalian multidrug resistance protein. Mol. Cell. Biol. 19:1999;2998-3009.
51. Wood V., Gwilliam R., Rajandream M.A., et al. The genome sequence of Schizosaccharomyces pombe. Nature. 415:2002;871-880.
52. Nishi K., Yoshida M., Nishimura M., et al. A leptomycin B resistance gene of Schizosaccharomyces pombe encodes a protein similar to the mammalian P-glycoproteins. Mol. Microbiol. 6:1992;761-769.
53. +, a novel gene of Schizosaccharomyces pombe which confers brefeldin A resistance, is structurally related to the ATP-binding cassette superfamily. J. Bacteriol. 177:1995;1536-1543.
54. Turi T.G., Rose J.K. Characterization of a novel Schizosaccharomyces pombe multidrug resistance transporter conferring brefeldin A resistance. Biochem. Biophys. Res. Commun. 213:1995;410-418.
55. Nguyen M.H., Peacock J.E., Morris A.J. The changing face of candidemia-emergence of non-Candida albicans species and antifungal resistance. Am. J. Med. 100:1996;617-623.
56. Sanglard D., Odds F.C. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2:2002;73-85.
57. Prasad R., De Wergifosse P., Goffeau A., Balzi E. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27:1995;320-329.
58. Sanglard D., Ischer F., Monod M., Bille J. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology. 143:1997;405-416.
59. Olliaro P., Cattani J., Wirth D. Malaria, the submerged disease. J. Am. Med. Assoc. 275:1996;230-233.
60. Fidock D.A., Nomura T., Talley A.K., et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell. 6:2000;861-871.
61. Gardner M.J., Hall N., Fung E., et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature. 419:2002;498-511.
62. Foote S.J., Thompson J.K., Cowman A.F., Kemp D.J. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell. 57:1989;921-930.
63. Wilson C.M., Serrano A.E., Wasley A., Bogenschutz M.P., Shankar A.H., Wirth D.F. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science. 244:1989;1184-1186.
64. Zalis M.G., Wilson C.M., Zhang Y., Wirth D.F. Characterization of the pfmdr2 gene for Plasmodium falciparum. Mol. Biochem. Parasitol. 62:1993;83-92.
65. Bozdech Z., Delling U., Volkman S.K., Cowman A.F., Schurr E. Cloning and sequence analysis of a novel member of the ATP-binding cassette (ABC) protein gene family from Plasmodium falciparum. Mol. Biochem. Parasitol. 81:1996;41-51.
66. Cowman A.F., Karcz S., Galatis D., Culvenor J.G. A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. J. Cell Biol. 113:1991;1033-1042.
67. Wellems T.E., Walker-Jonah A., Panton L.J. Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7. Proc. Natl. Acad. Sci. USA. 88:1991;3382-3386.
68. Su X., Kirkman L.A., Fujioka H., Wellems T.E. Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell. 91:1997;593-603.
69. Reed M.B., Saliba K.J., Caruana S.R., Kirk K., Cowman A.F. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature. 403:2000;906-909.
70. van Es H.H., Renkema H., Aerts H., Schurr E. Enhanced lysosomal acidification leads to increased chloroquine accumulation in CHO cells expressing the pfmdr1 gene. Mol. Biochem. Parasitol. 68:1994;209-219.
71. Hirst S.I., Stapley L.A. Parasitology: the dawn of a new millennium. Parasitol. Today. 16:2000;1-3.
72. Marsella R., Ruiz de Gopegui R. Leishmaniasis: a re-emerging zoonosis. Int. J. Dermatol. 37:1998;801-814.
73. Faraut-Gambarelli F., Piarroux R., Deniau M., et al. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob. Agents Chemother. 41:1997;827-830.
74. Légaré D., Cayer S., Singh A.K., Richard D., Papadopoulou B., Ouellette M. ABC proteins of Leishmania. J. Bioenerg. Biomembr. 33:2001;469-474.
75. Ouellette M., Haimeur A., Grondin K., Legare D., Papadopoulou B. Amplification of ABC transporter gene pgpA and of other heavy metal resistance genes in Leishmania tarentolae and their study by gene transfection and gene disruption. Methods Enzymol. 292:1998;182-193.
76. Callahan H.L., Beverley S.M. Heavy metal resistance: a new role for P-glycoproteins in Leishmania. J. Biol. Chem. 266:1991;18427-18430.
77. Papadopoulou B., Roy G., Dey S., Rosen B.P., Ouellette M. Contribution of the Leishmania P-glycoprotein-related gene ltpgpA to oxyanion resistance. J. Biol. Chem. 269:1994;11980-11986.
78. Légaré D., Papadopoulou B., Roy G., et al. Efflux systems and increased trypanothione levels in arsenite-resistant Leishmania. Exp. Parasitol. 87:1997;275-282.
79. Légaré D., Hettema E., Ouellette M. The P-glycoprotein-related gene family in Leishmania. Mol. Biochem. Parasitol. 68:1994;81-91.
80. Henderson D.M., Sifri C.D., Rodgers M., Wirth D.F., Hendrickson N., Ullman B. Multidrug resistance in Leishmania donovani is conferred by amplification of a gene homologous to the mammalian mdr1 gene. Mol. Cell. Biol. 12:1992;2855-2865.
81. Chow L.M., Wong A.K., Ullman B., Wirth D.F. Cloning and functional analysis of an extrachromosomally amplified multidrug resistance-like gene in Leishmania enriettii. Mol. Biochem. Parasitol. 60:1993;195-208.
82. Gueiros-Filho F.J., Viola J.P., Gomes F.C., et al. Leishmania amazonensis: multidrug resistance in vinblastine-resistant promastigotes is associated with rhodamine 123 efflux, DNA amplification, and RNA overexpression of a Leishmania mdr1 gene. Exp. Parasitol. 81:1995;480-490.
83. Chiquero M.J., Perez-Victoria J.M., O'Valle F., et al. Altered drug membrane permeability in a multidrug-resistant Leishmania tropica line. Biochem. Pharmacol. 55:1998;131-139.
84. Katakura K., Iwanami M., Ohtomo H., Fujise H., Hashiguchi Y. Structural and functional analysis of the LaMDR1 multidrug resistance gene in Leishmania amazonensis. Biochem. Biophys. Res. Commun. 255:1999;289-294.
85. Schmunis G.A., López Antunano F.J. Worldwide importance of parasites. Collier L., Balws A., Sussman M. 9th ed. Topley and Wilson's microbiology and microbial infections: parasitology. 5:1998;19-38 Arnold, London.
86. Cedeno J.R., Krogstad D.J. Susceptibility testing of Entamoeba histolytica. J. Infect. Dis. 148:1983;1090-1095.
87. Samarawickrema N.A., Brown D.M., Upcroft J.A., Thammapalerd N., Upcroft P. Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica. J. Antimicrob. Chemother. 40:1997;833-840.
88. Samuelson J., Ayala P., Orozco E., Wirth D. Emetine-resistant mutants of Entamoeba histolytica overexpress mRNAs for multidrug resistance. Mol. Biochem. Parasitol. 38:1990;281-290.
89. Borst P., Ouellette M. New mechanisms of drug resistance in parasitic protozoa. Annu. Rev. Microbiol. 49:1995;427-460.
90. Gomez M.D., Perez D.G., Ayala P., Samuelson J., Orozco E. Physiology and molecular biology of multidrug resistance in Entamoeba histolytica. Arch. Med. Res. 27:1996;421-425.
91. Bronchud M.H., Peters W.P. Selecting the right targets for cancer therapy. Brochud M.H., Foote M.A., Peters W.P., Robinson M.O. Principles of molecular oncology. 2000;3-27 Humana Press Inc, Totowa, NJ.
92. Biedler J.L., Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res. 30:1970;1174-1184.
93. Juliano R.L., Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta. 455:1976;152-162.
94. Riordan J.R., Ling V. Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J. Biol. Chem. 254:1979;12701-12705.
95. Shen D.W., Fojo A., Chin J.E., et al. Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science. 232:1986;643-645.
96. Kartner N., Riordan J.R., Ling V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science. 221:1983;1285-1288.
97. Kartner N., Evernden-Porelle D., Bradley G., Ling V. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature. 316:1985;820-823.
98. Chan H.S., Thorner P.S., Haddad G., Ling V. Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J. Clin. Oncol. 8:1990;689-704.
99. Chan H.S., Haddad G., Thorner P.S., et al. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N. Engl. J. Med. 325:1991;1608-1614.
100. Pirker R., Wallner J., Geissler K., et al. MDR1 gene expression and treatment outcome in acute myeloid leukemia. J. Natl. Cancer Inst. 83:1991;708-712.
101. Verrelle P., Meissonnier F., Fonck Y., et al. Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. J. Natl. Cancer Inst. 83:1991;111-116.
102. Arceci R.J. Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood. 81:1993;2215-2222.
103. Baldini N., Scotlandi K., Barbanti-Brodano G., et al. Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N. Engl. J. Med. 333:1995;1380-1385.
104. Lander E.S., Linton L.M., Birren B., et al. International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature. 409:2001;860-921.
105. Venter J.C., Adams M.D., Myers E.W., et al. The sequence of the human genome. Science. 291:2001;1304-1351.
106. Dean M., Rzhetsky A., Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 11:2001;1156-1166.
107. Cole S.P., Bhardwaj G., Gerlach J.H., et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1992;1650-1654.
108. Borst P., Evers R., Kool M., Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92:2000;1295-1302.
109. Harris A. Cystic fibrosis gene. Br. Med. Bull. 48:1992;738-753.
110. Jedlitschky G., Leier I., Buchholz U., Barnouin K., Kurz G., Keppler D. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 56:1996;988-994.
111. Nooter K., Brutel de la Riviere G., Look M.P., et al. The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer. Br. J. Cancer. 76:1997;486-493.
112. Arts H.J., Katsaros D., de Vries E.G., et al. Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma. Clin. Cancer Res. 5:1999;2798-2805.
113. König J., Nies A.T., Cui Y., Leier I., Keppler D. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim. Biophys. Acta. 1461:1999;377-394.
114. Taniguchi K., Wada M., Kohno K., et al. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res. 56:1996;4124-4129.
115. Cui Y., König J., Buchholz J.K., Spring H., Leier I., Keppler D. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol. Pharmacol. 55:1999;929-937.
116. Kool M., van der Linden M., de Haas M., et al. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc. Natl. Acad. Sci. USA. 96:1999;6914-6919.
117. Zeng H., Bain L.J., Belinsky M.G., Kruh G.D. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. Cancer Res. 59:1999;5964-5967.
118. Schuetz J.D., Connelly M.C., Sun D., et al. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat. Med. 5:1999;1048-1051.
119. Chen Z.S., Lee K., Kruh G.D. Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. J. Biol. Chem. 276:2001;33747-33754.
120. Chen Z.S., Lee K., Walther S., et al. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res. 62:2002;3144-3150.
121. Wijnholds J., Mol C.A., van Deemter L., et al. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc. Natl. Acad. Sci. USA. 97:2000;7476-7481.
122. Doyle L.A., Yang W., Abruzzo L.V., et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA. 95:1998;15665-15670.
123. Miyake K., Mickley L., Litman T., et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res. 59:1999;8-13.
124. Allikmets R., Schriml L.M., Hutchinson A., Romano-Spica V., Dean M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 58:1998;5337-5339.
125. Lage H., Dietel M. Effect of the breast-cancer resistance protein on atypical multidrug resistance. Lancet. Oncol. 1:2000;169-175.
126. van der Kolk D.M., Vellenga E., Scheffer G.L., et al. Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia. Blood. 99:2002;3763-3770.
127. van den Heuvel-Eibrink M.M., Wiemer E.A., Prins A., et al. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML). Leukemia. 16:2002;833-839.
128. Steinbach D., Sell W., Voigt A., Hermann J., Zintl F., Sauerbrey A. BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia. Leukemia. 16:2002;1443-1447.
129. Laing N.M., Belinsky M.G., Kruh G.D., et al. Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cells. Cancer Res. 58:1998;1332-1337.
130. Izquierdo M.A., Neefjes J.J., Mathari A.E., Flens M.J., Scheffer G.L., Scheper R.J. Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines. Br. J. Cancer. 74:1996;1961-1967.
131. Lage H., Perlitz C., Abele R., et al. Enhanced expression of human ABC-transporter tap is associated with cellular resistance to mitoxantrone. FEBS. Lett. 503:2001;179-184.
132. Saier M.H. Jr, Paulsen I.T., Sliwinski M.K., Pao S.S., Skurray R.A., Nikaido H. Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria. FASEB J. 12:1998;265-274.
133. Vulevic B., Chen Z., Boyd J.T., et al. Cloning and characterization of human adenosine 5'-triphosphate-binding cassette, sub-family A, transporter 2 (ABCA2). Cancer Res. 61:2001;3339-3347.
134. Ueda K., Yoshida A., Amachi T. Recent progress in P-glycoprotein research. Anticancer Drug Des. 14:1999;115-121.
135. Ruetz S., Gros P. Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell. 77:1994;1071-1081.
136. Childs S., Yeh R.L., Hui D., Ling V. Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein. Cancer Res. 58:1998;4160-4167.
137. Gerloff T., Stieger B., Hagenbuch B., et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J. Biol. Chem. 273:1998;10046-10050.
138. de Jong M.C., Slootstra J.W., Scheffer G.L., et al. Peptide transport by the multidrug resistance protein MRP1. Cancer Res. 61:2001;2552-2557.
139. Jedlitschky G., Burchell B., Keppler D. The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J. Biol. Chem. 275:2000;30069-30074.